Tirzepatide for Weight Loss | Zepbound & GLP-1 Telehealth Prescription

Physician-Prescribed
Dual GIP/GLP-1 Receptor Agonist

Tirzepatide for
Advanced Weight Loss

Next-generation dual-action therapy with up to 22.5% body weight reduction in clinical trials. The most effective weight loss medication available.

See If You Qualify →
22.5%
Max Weight Loss
Weekly
Injection
Dual
Action
Compounded Tirzepatide Vial

How Tirzepatide Treatment Works

A physician-supervised process from assessment to delivery

1
Online Assessment
Complete a health questionnaire about your medical history and weight goals.
2
Doctor Reviews
A board-certified physician reviews your profile within 24 hours.
3
Prescription Issued
If approved, your doctor prescribes the right starting dose.
4
Home Delivery
Medication ships directly to your door with free shipping.

About Tirzepatide

The next generation of weight management medication

What is Tirzepatide?

Tirzepatide is the first dual GIP and GLP-1 receptor agonist, meaning it activates two different hormone pathways simultaneously. This dual mechanism produces stronger appetite suppression and metabolic benefits than single-action medications, making it the most effective weight loss medication studied to date.

How Does It Work?

By targeting both GIP and GLP-1 receptors, Tirzepatide enhances insulin sensitivity, reduces appetite through two pathways, slows gastric emptying, and improves how your body processes and stores fat. The dual action means better results than GLP-1-only medications.

Dosing Schedule

  • Once-weekly subcutaneous injection
  • Starting dose: 2.5mg weekly for 4 weeks
  • Gradual increase to 5mg, 7.5mg, 10mg, 12.5mg, or 15mg
  • Physician-guided titration based on your response
  • Maximum dose: 15mg weekly

Clinical Results

  • Up to 22.5% body weight reduction in clinical trials
  • Superior results compared to single-action GLP-1 medications
  • Significant improvements in A1c and blood sugar
  • Reductions in blood pressure and triglycerides
  • Improvements in metabolic health markers

Common Side Effects

Similar to other GLP-1 medications, the most common side effects include nausea (typically during dose increases), diarrhea, decreased appetite, constipation, and mild injection site reactions. Most side effects diminish as your body adjusts over the first few weeks.

Tirzepatide vs. Semaglutide

  • Tirzepatide targets two receptors (GIP + GLP-1) vs. one
  • Higher average weight loss in head-to-head trials
  • Stronger metabolic improvements
  • Similar side effect profile
  • Your physician recommends the best option for you

Frequently Asked Questions

Common questions about Tirzepatide treatment

How is Tirzepatide different from Semaglutide?
Tirzepatide activates two hormone receptors (GIP and GLP-1) while Semaglutide activates only one (GLP-1). This dual action typically produces greater weight loss — up to 22.5% vs 15-20% — and stronger metabolic benefits. Your physician will recommend which is best for your specific situation.
Is this the same as Mounjaro or Zepbound?
Tirzepatide is the active ingredient in both Mounjaro (approved for diabetes) and Zepbound (approved for weight management). Our physicians prescribe compounded tirzepatide, which contains the same active ingredient.
How long until I see results?
Many patients notice appetite changes within the first 1-2 weeks. Significant weight loss typically becomes measurable within 4-8 weeks, with the most dramatic results occurring over 3-6 months.
Who qualifies for Tirzepatide?
Generally, adults with a BMI of 30+ or adults with a BMI of 27+ who have weight-related health conditions may qualify. Your physician evaluates your complete health profile to determine if Tirzepatide is appropriate and safe for you.

Ready to Get Started?

Complete a quick health assessment and a licensed physician will review your eligibility within 24 hours.

See If You Qualify — It's Free →
Telehealth services powered by CareAxia · Licensed physicians · HIPAA compliant